PharmNovo
0 followers
‌
PharmNovo addresses the high unmet need of treatments for chronic pain, which affects up to 30% of the adult population in the USA & Europe.
Industries
Headquarters
Employees
Links
Org chart
Per von Mentzer
Collapse
David Kendall
Chief Scientific Officer
Thomas Eskildsen
Senior Clinical Trial Manager
Jarkko Kalliomäki
Clinical lead
Petra Larson
Communications Lead
Olof Breuer
Consultant Clinical Pharmacologist
Bengt von Mentzer
Chief Scientific Advisor, Founder
Jesper Vallentin Kjerulff
Chief Operating Officer
